The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Vascular Adrenoceptors: An Update
Abstract
The total and regional peripheral resistance and capacitance of the vascular system is regulated by the sympathetic nervous system, which influences the vasculature mainly through changes in the release of catecholamines from both the sympathetic nerve terminals and the adrenal medulla. The knowledge of the targets for noradrenaline and adrenaline, the main endogenous catecholamines mediating that influence, has recently been greatly expanded. From two types of adrenoceptors (alpha and beta), we have now nine subtypes (alpha1A, alpha1B, alpha1D, alpha2A/D, alpha2B, alpha2A/D, beta1, beta2, and beta3) and two other candidates (alpha1L and beta4), which may be conformational states of alpha1A and beta1-adrenoceptors, respectively. The vascular endothelium is now known to be more than a pure anatomical entity, which smoothly contacts the blood and forms a passive barrier against plasma lipids. Instead, the endothelium is an important organ possessing at least five different adrenoceptor subtypes (alpha2A/D, alpha2C, beta1, beta2, and beta3), which either directly or through the release of nitric oxide actively participate in the regulation of the vascular tone. The availability of transgenic models has resulted in a stepwise progression toward the identification of the role of each adrenoceptor subtype in the regulation of blood pressure and fine-tuning of blood supply to the different organs: alpha2A/D-adrenoceptors are involved in the central control of blood pressure; alpha1-(primarily) and alpha2B-adrenoceptors (secondarily) contribute to the peripheral regulation of vascular tone; and alpha2A/D- and alpha2C-adrenoceptors modulate transmitter release. The increased knowledge on the involvement of vascular adrenoceptors in many diseases like Raynaud's, scleroderma, several neurological degenerative diseases (familial amyloidotic polyneuropathy, Parkinson disease, multiple-system atrophy), some kinds of hypertension, etc., will contribute to new and better therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · cited 1×
“Soon after the discovery of the EDRF (Furchgott and Zawadzki, 1980)—later on identified with NO—(Ignarro et al., 1987; Palmer et al., 1987), it was demonstrated that activation of a2-adrenoceptors on endothelial cells stimulates the release of NO, an action that would tend to attenuate vasoconstriction produced by act…”
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768 · cited 1×
“As suggested by Folkow (1982), the development of hypertension by this mechanism may be restricted to a specific subset of individuals genetically predisposed to high blood pressure.”
On some physiological actions of ergot
Dale, H. H. (1906) · The Journal of Physiology · doi:10.1113/jphysiol.1906.sp001148 · Cited by 1,011
Winzer-Serhan, U. H., Raymon, H. K., Broide, R. S., Chen, Y., & Leslie, F. M. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00369-7 · Cited by 96
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Storch, C. H., & Hoeger, P. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09848.x · Cited by 526
α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostate
Michel, M. C., & Vrydag, W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706619 · Cited by 437
Pathogenesis of Raynaud's phenomenon
Herrick, A. L. (2005) · Rheumatology · doi:10.1093/rheumatology/keh552 · Cited by 408
Adrenergic regulation of innate immunity: a review
Scanzano, A., & Cosentino, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00171 · Cited by 323
Metadata
- Authors
- Guimarães, S., & Moura, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 53
- Issue
- 2
- Pages
- 319-356
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2150341119
- Cited by
- 700
- References
- 5
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular Adrenoceptors: An Update. https://app.cochat.ai/papers/10.1016/s0031-6997(24)01495-9
- The paper
- Guimarães, S., & Moura, D. (2001). Vascular Adrenoceptors: An Update. Pharmacological Reviews. https://doi.org/10.1016/s0031-6997(24)01495-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.